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The release of extracellular traps (ETs) is a recently describedmechanism of innate immune
response to infection. Although ETs have been intensely investigated in the context of
neutrophil antimicrobial effector mechanisms, other immune cells such as mast cells,
eosinophils, and macrophages can also release these structures. The different ETs have
several features in common, regardless of the type of cells from which they originated,
including a DNA backbone with embedded antimicrobial peptides, proteases, and his-
tones. However, they also exhibit remarkable individual differences such as the type of
sub-cellular compartments from where the DNA backbone originates (e.g., nucleus or
mitochondria), the proportion of responding cells within the pool, and/or the molecular
mechanism/s underlying the ETs formation. This review summarizes the knowledge accu-
mulated in recent years regarding the complex and expanding world of ETs and their role
in immune function with particular emphasis on the role of other immune cells rather than
on neutrophils exclusively.
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INTRODUCTION
Extracellular traps (ETs) were ﬁrst described in 2004 in a ground
breaking publication by Brinkmann and colleagues who observed
the released of web-like structures by neutrophils after stimula-
tion with phorbol myristate acetate (PMA), lipopolysaccharides
(LPS), interleukin 8 (IL-8), platelet-mediated neutrophil acti-
vation (Clark et al., 2007) and after exposure to Gram-positive
or Gram-negative bacteria (Brinkmann et al., 2004). The com-
position of these structures has been intensively investigated
during recent years. Besides the backbone formed by DNA
and histones, ETs also comprise a number of molecules which
impart an antimicrobial effect including elastase, cathepsin G,
proteinases or defensins, bacterial permeability increasing pro-
tein (BPI), or myeloperoxidase (MPO; Brinkmann et al., 2004;
Papayannopoulos et al., 2010).
In recent years it has become increasingly evident that ETs
are not formed exclusively by neutrophils but also by other cell
types including, mast cells (von Kockritz-Blickwede et al., 2008),
eosinophils (Youseﬁ et al., 2008), chicken heterophils (Chuam-
mitri et al., 2009), and macrophages/monocytes (Chow et al.,
2010). The molecules, microorganisms, and microbial products
that are able to induce ETs formation by various cell types are
summarized in Table 1.
Apart from humans and mice, ETs have also been found to
be released by cells from a variety of other animals including ox,
horses, ﬁsh, cats, and even by invertebrates. In fact, extracellu-
lar nucleic acid released by oenocytoid cells has been reported to
be an important defense mechanism toward pathogenic microor-
ganisms in insects (Altincicek et al., 2008). ETs are also apparent
in plants where they have been demonstrated to play an important
role in defense against fungal infections of the root tip (Wen et al.,
2009; Hawes et al., 2011). The common feature of ETs released by
the different cell types is a backbone composed of DNA decorated
with antimicrobial molecules that is capable of snaring and killing
a wide spectrum of microbes (Brinkmann et al., 2004; Fuchs et al.,
2007; Urban and Zychlinsky, 2007; von Kockritz-Blickwede and
Nizet, 2009). Nevertheless, it should be mentioned that ETs aris-
ing from different cell types also exhibit unique features, distinct
from those originally described for neutrophils.
Much of the research on ETs has been conducted on neu-
trophils, most probably because these cells were the ﬁrst to be
associated with the production of such extracellular structures.
This is also the reason why the mechanism of cell death lead-
ing to the formation of ETs was ﬁrst termed Netosis (Fuchs et al.,
2007) and then later generalized to Etosis. The differences between
Etosis and the other forms of cell death such as necrosis or apop-
tosis are summarized in Table 2. The intracellular signaling events
reported to be involved in the induction of etosis includes the
activation of NADPH oxidase with the concomitant formation
of reactive oxygen radicals (ROS; Papayannopoulos et al., 2010;
Guimaraes-Costa et al., 2012). There are also reports demonstrat-
ing that, in addition to chromosomal DNA, mitochondrial DNA
could also be used by eosinophils (Youseﬁ et al., 2008) and neu-
trophils (Youseﬁ et al., 2009) to form ETs without induction of cell
death. However, the mechanism/s behind this unusual mode of
ET formation remains a mystery. Although the primary function
of ETs has been attributed to their antimicrobial effect, the overall
role of ETs in host defense against pathogens remains a topic of
debate.
THE MOLECULAR BASIS OF EXTRACELLULAR TRAPS
FORMATION
While signiﬁcant progress has beenmade in unraveling the cellular
processes that are taking place during the formation of ETs, many
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Table 1 | Differences between netosis, apoptosis, and necrosis.
Necrosis Apoptosis Netosis
Membrane and organelle disintegration Membrane blebbing Vacuolization
Phosphatidylserine exposure during early steps of necrosis Phosphatidylserine exposure No exposure to Phosphatidylserine
Cellular swelling and bursting Nuclear chromatin condensation without
disintegration of the nuclear membrane
Nuclear chromatin decondensation with
disintegration of the nuclear membrane
Cell damage releasing the intracellular contents Programmed cell death Programmed cell death
Table 2 | Cell types shown to release ETs and triggering stimuli.
Cell type Activating agent Reference
Neutrophils IL-8 Ramos-Kichik et al. (2009)
Neutrophils, Mast cells Lipopolysaccharide (LPS) Brinkmann et al. (2004), von Kockritz-Blickwede et al. (2008),
Ramos-Kichik et al. (2009)
Neutrophils, Mast cells Phorbol-12-myristate-13-acetate (PMA) Brinkmann et al. (2004), von Kockritz-Blickwede et al. (2008)
Neutrophils Platelet via TLR4 Clark et al. (2007)
Neutrophils, Eosinophils Interferon (IFN) γ + C5a Youseﬁ et al. (2008)
Eosinophils Interferon (IFN) α + C5a Youseﬁ et al. (2008)
Eosinophils Interferon (IFN) + eotaxin Youseﬁ et al. (2008)
Neutrophils GM-CSF + C5a Martinelli et al. (2004), Youseﬁ et al. (2009)
Neutrophils GM-CSF + LPS Martinelli et al. (2004), Youseﬁ et al. (2009)
Neutrophils Lipophosphoglycan Guimaraes-Costa et al. (2009)
Neutrophils, Mast cells M1-protein-ﬁbrinogen complex Lauth et al. (2009), Oehmcke et al. (2009)
Neutrophils, Mast cells, Eosinophils Hydrogen peroxide Brinkmann et al. (2004), von Kockritz-Blickwede et al. (2008),
Oehmcke et al. (2009)
Neutrophils Calcium Wang et al. (2009)
Neutrophils, Mast cells Glucose oxidase Fuchs et al. (2007), von Kockritz-Blickwede et al. (2008)
Mast cells IL-23 and IL-1β Lin et al. (2011)
Neutrophils, Monocytes/Macrophages Statins Chow et al. (2010)
Neutrophils Tumor necrosis factor (TNF) α Wang et al. (2009)
Neutrophils Panton-Valentin leukocidin Pilsczek et al. (2010)
Neutrophils Platelet activating factor Hakkim et al. (2011)
aspects still remain unresolved. ET formation generally begins
in stimulated cells with the loss of the tight organization of the
nuclei followed by chromatin decondensation. The characteristic
shape of the nuclei disappears and a gap between the inner and
outer membrane of the nucleus emerges. Formation of vesicles in
the nuclear membrane follows leading to widespread membrane
disruption. At the same time, disruption of the granular mem-
branes takes place in the cell cytoplasm facilitating the mixing of
granular content with the chromatin leaking into the cytoplasm
through the disrupted cellular membrane. Finally, eruption of the
cell membrane follows and DNA mixed with the granular con-
tent is released into the extracellular milieu (Fuchs et al., 2007).
This characteristic form of cell death, termed Netosis by Stein-
berg and Grinstein (2007), was described earlier by Takei et al.
(1996) although without showing an association with the release
of ETs. Netosis seems to be a process entirely independent of
caspases and certain kinases such asRIP-1 and is not affected by the
caspase inhibitor zVAD-fmk (Urban et al., 2009; Remijsen et al.,
2011). Netosis is not associated with DNA fragmentation or phos-
phatidylserine (PS) exposure on the outer leaﬂet of the cellular
membrane, which are distinctive aspects of apoptosis. The lack of
PS impedes the clearance of cells undergoing netosis by phagocytic
cells such asmacrophages. An additional feature that distinguishes
netosis fromapoptosis and necrosis is the fact that both the nuclear
as well as the granular membranes undergo fragmentation.
A critical factor involved in etosis and ET formation is the
production of ROS. In neutrophils, ROS produced by NADPH
oxidases has been reported to inactivate caspase function thereby
leading to the blockage of the apoptotic cell death pathway (Fadeel
et al., 1998; Hampton et al., 2002). The importance of NADPH
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oxidase for ET release was demonstrated by the reduced capac-
ity of neutrophils to form ETs after pharmacological inhibition of
this enzyme (Metzler et al., 2011). Furthermore, neutrophils from
patients suffering from chronic granulomatous diseases, which
are defective in NADPH oxidase function, are unable to form ETs
(Fuchs et al., 2007; Bianchi et al., 2009). Etosis is nevertheless a
multifactorial process and NADPH oxidase activity is necessary
but alone is insufﬁcient to trigger this process. Thus, increased
intracellular Ca2+ levels after treatment with Thapsigargin has
also been shown to induce ET formation in neutrophils (Gupta
et al., 2010). The increased Ca2+ level induces a Ca2+-dependent
PAD4 activity leading to histone citrullination, which constitutes
a downstream signaling processes in the formation of ETs (Neeli
et al., 2008; Wang et al., 2009). Indeed, PAD4-dependent citrulli-
nation of histone H3 is a key molecular event in the formation of
ETs (Neeli et al., 2008; Wang et al., 2009; Figure 1).
Even though the development of ROS and the activity of
NADPH oxidase have been claimed as being essential in the for-
mation of ETs, it has also been reported that microorganisms such
as Staphylococcus aureus (Pilsczek et al., 2010) or Leishmania dono-
vani (Gabriel et al., 2010) are able to induce ET release through a
molecular process that is independent of ROS. This adds a further
level of complexity to the molecular puzzle of this cellular process.
EXTRACELLULAR TRAPS FORMATION OUTSIDE THE
NEUTROPHIL WORLD
As mentioned before, other immune cells including mast cells,
eosinophils, and macrophages are also capable of releasing ETs.
Although the molecular principles underlying the formation of
ETs bymast cells (vonKockritz-Blickwede et al., 2008), eosinophils
(Youseﬁ et al., 2008), and monocytes/macrophages (Chow et al.,
2010) share some similarities with those observed for neutrophils,
there are some notable disparities. The most remarkable mech-
anism of ET formation has been described in eosinophils. In
these cells, ETs are formed by both nuclear and mitochondrial
DNA in a ROS-dependent manner. The presence of several mito-
chondrial genes including Co1 (cytochrome oxidase subunit 1),
ND1 (NADH dehydrogenase subunit 1), or Cyb (cytochrome b)
in the nucleic acid material released by eosinophils provides clear
evidence of its mitochondrial origin (Youseﬁ et al., 2008). DNA
is rapidly expelled by the eosinophils in response to stimulation
with LPS, eotaxin, complement factor 5a (C5a) or infection with
Gram-negative bacteria after priming with interleukin 5 (IL-5) or
IFN-γ (Figure 1), which, in this case, was shown to be essen-
tial for the explosive release of mtDNA by eosinophils. The time
frame reported for the release of eosinophil ETs is seconds and
is thus much shorter than the classical ET formation by neu-
trophils. An additional and interesting characteristic of ETs formed
by eosinophils is the lack of cytosolic proteins, although eosinophil
granule proteins were shown to be released concurrently with
mtDNA (Youseﬁ et al., 2012). An additional and important fea-
ture that differentiates the eosinophil from the classical neutrophil
release of ETs is that it is not dependent upon the cell death of the
eosinophils. Interestingly, a similar mechanism of ET release that
is non-associated with cell death has also been recently described
for neutrophils (Pilsczek et al., 2010). This challenges the gener-
alized opinion that ETs are released by dying cells. Nevertheless,
it should also be noted that in both cases where ET formation
was non-associated with cell death, the cells needed to be primed
ﬁrst before stimulated to form ETs. In the case of neutrophils,
cells were initially activated by granulocyte/macrophage stimulat-
ing factor (GM-CSF) followed by short-term toll-like receptor 4
(TLR4) or C5a stimulation (Figure 1). In these experimental con-
ditions, viable neutrophils were able to release ETs that contained
mitochondrial but no nuclear DNA.
DNA-releasing eosinophils have been primarily reported in the
context of inﬂammatory diseases of the intestine (Youseﬁ et al.,
2008) and skin (Simon et al., 2011). They seem to be less promi-
nent, however, in the setting of infectious diseases despite the
fact that these structures are also capable of snaring and killing
bacteria (Youseﬁ et al., 2008). Furthermore, while induction of
mtDNA associated with eosinophil granules has been reported to
contribute to the increased survival of mice (up to 14 days) under-
going cecal ligation puncture (CLP; Youseﬁ et al., 2008), it is still
not clear to what extent eosinophil ET formation contributes to
host defense. In this regard, though evidence has been provided
that hypereosinophilic transgenic animals are less susceptible to
septicemia induced by CLP, the major role of eosinophils has
been attributed to host defense against helminths (Blanchard and
Rothenberg, 2009; Linch et al., 2009). These granulocytic cells are
able to inﬁltrate the gastrointestinal tract and have been associ-
ated with a variety of inﬂammatory conditions like inﬂammatory
bowl disease (IBD) or eosinophil-associated gastrointestinal dis-
orders (EGIDs; DeBrosse and Rothenberg, 2008; Wedemeyer and
Vosskuhl, 2008).
Besides eosinophils, mast cells, which also originate from bone
marrow and contain different types of granules enclosing very
potent biological effectors molecules, are also capable of releas-
ing ETs following stimulation (Figure 2). Mast cells are located
in close proximity to the host environment where they are most
likely to encounter incoming pathogens. Although mast cells are
largely known for their detrimental role in the context of aller-
gic diseases, there is a growing body of evidence that suggests
that they are also important contributors to host defense against
pathogens (Galli and Wershil, 1996; Bischoff, 2007). Thus, mast
cells are not only important for modulating the function of other
immune cells (e.g., neutrophils) during infection but they also
impart direct antimicrobial effects (Feger et al., 2002). Due to
the limited phagocytic activity of mast cells, their antimicrobial
activity is largely mediated by extracellular mechanisms includ-
ing degranulation and the concomitant release of highly potent
antimicrobial peptides such as cathelicidins (CRAMP or LL-37),
defensins (β-defensins) or proteases (tryptase, chymase). Mast cell
degranulation occurs after exposure to pathogens and has been
shown to be very efﬁcient in inhibiting the growth of bacteria
such as S. aureus (Abel et al., 2011). In addition, mast cells are
also able to release ETs in a ROS-dependent manner. Mast cell ETs
are composed of DNA and histones, which are the general compo-
nents of most ETs, as well asmast cell-speciﬁc granule proteins like
tryptase andCRAMP/LL-37 (vonKockritz-Blickwede et al., 2008).
In contrast to neutrophils where NETs can be dismantled after
treatment with only DNase, the complete disassembling of mast
cell ETs requires treatment with DNase as well as the addition of
enzymes degrading tryptase (e.g., MPO; von Kockritz-Blickwede
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FIGURE 1 | Schematic representation of the cellular processes involved
in the formation of ETs.The process can be triggered by a number of stimuli
including, PMA, LPS, C5a + GM-CSF, IFN α/γ. LPS, bacteria, and viruses. IL-8
is also able to trigger ET release by interacting with the CXCL2/8 receptor and
inducing H3 citrullination through PAD4 activation via Src kinases. Most
pathways converge in the activation of the key enzyme NADPH oxidase. This
enzyme is highly activated by PMA and formylated peptides. Induction of the
fMLP receptor leads to a massive activation of protein kinase C (PKC) and
NADPH oxidase activity. On the other hand, fMLP blocks autophagy
via PI3K, Akt and mTOR activation, which is able to prevent Etosis. NADPH
oxidase activity results in ROS production and H3 citrullination leading to
chromatin decondensation and nuclear collapse. Disintegration of the nuclear
membrane and adsorption of antimicrobial granular proteins onto the
decondensed chromatin network is the ﬁnal step of Etosis that precedes the
release of ETs into the surrounding milieu after rupture of the plasma
membrane.
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FIGURE 2 | Release of ETs by mast cells after encounter with
S. pyogenes. (A) Field-emission scanning electron microscope
(FESEM) images of a resting mast cell (bar, 2 μm). (B,C) Mast cells
in the process of releasing ETs in response to S. pyogenes (B, bar,
5 μm and C, bar, 2 μm). (D) S. pyogenes captured in ETs
(bar, 1 μm). Provided by M. Rohde, Department of Microbial
Pathogenesis, Helmholtz Center for infection Research, Braunschweig,
Germany.
et al., 2008). Another interesting feature is the recently reported
involvement of the transcriptional hypoxia-inducible factor 1α
(HIF-1α) in the modulation of ET release by human and murine
mast cells (Branitzki-Heinemann et al., 2012). HIF is awell-known
factor for its role in the regulation of the inﬂammatory and innate
immune function of neutrophils and macrophages (Cramer et al.,
2003; Peyssonnaux et al., 2005).
Most recently, monocytes/macrophages have also been
reported to be capable of releasing ETs (Chow et al., 2010; Aulik
et al., 2011). Macrophage ET production has been shown to be
boostedby statins,which are inhibitors of the rate-limiting enzyme
within the cholesterol biosynthesis 3-hydroxy 3-methyglutaryl
coenzyme A (HMG-CoA) reductase. In addition, increased pro-
duction of ETs release by macrophages has been observed after
inhibition of HMG-CoA reductase using siRNA or after treat-
ment of macrophages with the downstream HMG-CoA reductase
product mevalonate (Chow et al., 2010). Statins are also capable
of inhibiting the release of ETs by neutrophils. The molecular
mechanism mediating the effect of statins on phagocytes seems
to be linked to the inhibition of the sterol pathway within the
cell (Chow et al., 2010). Interestingly, bacterial components such
as hemolysins of Escherichia coli or leukotoxin of Mannheimia
haemolytica have been shown to induce the release of ETs by bovine
macrophages (Aulik et al., 2011, 2012). However, the extent to
which the molecular processes leading to the formation of ETs by
monocytes/macrophages is comparable to themechanisms already
described for neutrophils, eosinophils, and mast cells, remains to
be elucidated. Although little information is available regarding
the molecular basis of ET release by macrophages, it seems that
general mechanisms such as NADPH oxidase dependency and
oxidative stress are involved (Chow et al., 2010).
THE ANTIMICROBIAL EFFECT OF EXTRACELLULAR TRAPS
Extracellular traps release is thought to be mainly an antimicro-
bial strategy used by host cells to control and eliminate pathogens
(Brinkmann et al., 2004; vonKockritz-Blickwede et al., 2008; Linch
et al., 2009; Saitoh et al., 2012). Thus, a number of bacteria, fungi,
and parasites have been reported in the literature to be entrapped
and killed by ETs (summarized in Table 3). Saitoh et al. (2012)
provided the ﬁrst report regarding the involvement of ETs in
antiviral immunity. Their study showed that neutrophils are able
to produce ETs in response to human immunodeﬁciency virus-1
(HIV-1) and, more interestingly, that these virus particles can be
entrapped and neutralized by the ETs. By using blocking antibod-
ies to MPO and α-defensin, it was possible to demonstrate that
the viral neutralization was dependent on the presence of MPO
and α-defensin in the NET structure. The production of NETs
by neutrophils in this case was associated with TLR-7 and TLR-8
signaling as well as with ROS production (Saitoh et al., 2012). In
addition, the investigators also showed that the anti-inﬂammatory
cytokine IL-10 could reduce the release of extracellular DNA by
neutrophils into the surrounding milieu. It is important to note,
however, that these studies were carried out in vitro and, although
this is an exciting new aspect of ET function in host immu-
nity, it still remains to be demonstrated in the in vivo setting.
Whether ETs produced by immune cells other than neutrophils
are also capable of trapping and inactivating virus particles may
be deserving of future investigation. The ﬁnding that different
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Table 3 | Microorganisms able to trigger the release of ETs by specific cell types.
Microorganism Cell type Reference
Aspergillus fumigatus Neutrophils Bruns et al. (2010), McCormick et al. (2010)
Candida albicans Neutrophils Urban et al. (2006)
Cryptococcus gattii Neutrophils Springer et al. (2010)
Cryptococcus neoformans Neutrophils Urban et al. (2009)
Eimeria bovis Neutrophils Behrendt et al. (2010)
Enterococcus faecalis Neutrophils Lippolis et al. (2006)
Escherichia coli Neutrophils, monocytes Lippolis et al. (2006), Grinberg et al. (2008), Webster et al. (2010)
Haemophilus inﬂuenzae Neutrophils Hong et al. (2009), Hakkim et al. (2011)
Helicobacter pylori Neutrophils Hakkim et al. (2011)
Human Immunodeﬁciency Virus-1 (HIV-1) Neutrophils Saitoh et al. (2012)
Klebsiella penumoniae Neutrophils Papayannopoulos et al. (2010)
Leishmania amazonensis Neutrophils Guimaraes-Costa et al. (2009)
Listeria monocytogenes Neutrophils Ermert et al. (2009)
Mycobacterium canettii Neutrophils Ramos-Kichik et al. (2009)
Mycobacterium tuberculosis Neutrophils Ramos-Kichik et al. (2009)
Pseudomonas aeruginosa Mast cells von Kockritz-Blickwede et al. (2008)
Serratia marcescens Neutrophils Lippolis et al. (2006)
Shigella ﬂexneri Neutrophils Brinkmann et al. (2004)
Staphylococcus aureus Neutrophils, Mast cells Brinkmann et al. (2004), von Kockritz-Blickwede et al. (2008)
Streptococcus dysgalactiae Neutrophils Lippolis et al. (2006)
Streptococcus pneumoniae Neutrophils, Mast cells Beiter et al. (2006), Crotty Alexander et al. (2010)
Streptococcus pyogenes Neutrophils, Mast cells Buchanan et al. (2006), von Kockritz-Blickwede et al. (2008)
pathogens are able to induce ETs in different innate immune cells
argues for a general role of ETs in the innate immune response
to pathogenic microorganisms and is supported by a number
of in vivo studies revealing ET formation in necrotizing soft
tissue infections caused by S. pyogenes (Buchanan et al., 2006),
polymicrobial sepsis after cecal ligation and puncture (Youseﬁ
et al., 2008) and S. pneumoniae infections in murine models
(Buchanan et al., 2006).
The molecular mechanism/s responsible for the entrap-
ment and killing of microorganisms within ETs is a matter of
debate, though several hypotheses have been proposed. One
such hypothesis is that entrapment is facilitated by the occur-
rence of electrostatic interactions arising from the cationically
chargedET structure and the anionically charged bacterial surfaces
(Brinkmann and Zychlinsky, 2007). The subsequent killing of
the pathogen is postulated to arise from the ability of the ETs to
increase the local concentration of certain antimicrobial peptides
and therefore intensifying the contact between microorganisms
and the antimicrobial agents (vonKockritz-Blickwede et al., 2008).
Potential candidates being discussed to have antimicrobial prop-
erties within ETs are the histones. Several types of histones
and histone-related peptides isolated from various organisms
and cell types exhibit a broad spectrum of antimicrobial activ-
ities (Kawasaki and Iwamuro, 2008). In particular, the histone
H2B displays antimicrobial properties against Gram-positive and
Gram-negative bacteria and fungi (Li et al., 2007). An overview
of the antimicrobial activities of histones is displayed in Table 4.
In addition to histones, there are other cell speciﬁc components
Table 4 | Short overview of histones and their antimicrobial properties.
Histone Origin Antimicrobial spectrum Reference
Histone H1 macrophages, epithelial cells, liver,
intestine, skin
S. aureus, L. moncytogenes, S. typhimurium, E. coli,
C. neoformans
Hiemstra et al. (1993),
Rose et al. (1998)
Histone H2A Placenta, skin, liver E. coli, S. aureus, B. subtilis, S. ﬂexneri, S. typhimurium,
S. pneumonia, C. albicans
Kim et al. (2002), Cho et al. (2002),
Fernandes et al. (2002), Li et al. (2007)
Histone H2B Placenta, skin, liver S. aureus, L. moncytogenes, S. typhimurium, B. subtilis Li et al. (2007)
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located within the ETs that may have antimicrobial effect. The two
most important antimicrobial peptide families in mammals are
the defensins (Lehrer and Ganz, 2002b) and a group of cationic
molecules, classiﬁed as cathelicidins (Lehrer and Ganz, 2002a;
Zaiou andGallo, 2002). Cathelicidins belong to a family of antimi-
crobial peptides found in the lysosomes of several immune cells
including neutrophils, mast cells, and macrophages (Nizet et al.,
2001; Zanetti, 2004). The presence of these antimicrobial pep-
tides has been demonstrated in ETs released by neutrophils as well
as by mast cells (Brinkmann et al., 2004; von Kockritz-Blickwede
et al., 2008). However, the question remainswhether antimicrobial
peptides bound to the DNA backbone of the ETs still retain their
antimicrobial capacity.
Although the antimicrobial effect of ETs has been extensively
demonstrated in many experimental settings, the extent to which
these structures contribute to pathogen killing during productive
infection remains a subject of debate. Furthermore, in certain cir-
cumstances, the production of ETs can be detrimental for the host.
For example, the release of high quantities of DNA and histones
can induce autoimmune reactions that may be involved in the
development of autoimmune diseases like lupus erythematosus
or rheumatoid arthritis (Mohan et al., 1993; Zhong et al., 2007).
Preeclampsia, a severe disorder of late pregnancy characterized by
an increasing level of cell free DNA in the maternal plasma, is
another pathological disorder in which ET formation may also be
involved (Clark et al., 1998). In this disorder, a massive release of
DNA probably in response to high levels of inducing factors (e.g.,
IL-8 or microdebris of the placenta) has been observed (Gupta
et al., 2005, 2007). Similarly, the release of ETs by platelet-activated
neutrophils under blood ﬂow conditions can result in reduced
blood perfusion of the tissue and ischemia (Clark et al., 2007).
The beneﬁcial or detrimental effect of ETs can be determined
by the extent of the response. Moderate release of ETs during
infection can contribute to pathogen killing and control of the
infection, thus conferring a beneﬁcial effect. Conversely, massive
release of ETs during pathological conditions can induce autoim-
munity as well as organ damage and is thus highly deleterious for
the host.
PATHOGEN EVASION OF EXTRACELLULAR TRAPS
Successful pathogens have evolved intricate countermeasures to
subvert the mechanisms of host defense. Shortly after ETs were
discovered, a number of studies reported the ability of certain
pathogens to circumvent the antimicrobial activity of these struc-
tures. One of the main strategies used by pathogenic bacteria to
escape the ETs is through the production of DNases that cleave
DNA and therefore dismantle their DNA backbone. This mech-
anism has been described for S. pyogenes, which produces a very
potent bacteriophage-encoded DNase designated Sda1. Strains of
S. pyogenes producing Sda1 are more resistance to ET-dependent
killing than strains lacking the Sda1 gene (Sumby et al., 2005;
Buchanan et al., 2006). A similar strategy has been reported for
S. pneumoniae (Buchanan et al., 2006) and S. aureus (Udou and
Ichikawa, 1979; Berends et al., 2010). Changes in the composition
of the bacterial cell wall can also help to avoid the antimicro-
bial activity of ETs. Thus, S. pneumoniae mutant strains lacking
positively charged D-alanyl residues on their lipoteichoic acid
(LTA) have been shown to be more susceptible to ET killing than
the corresponding wild-type strain (Wartha et al., 2007a,b). D-
alanylation of LTA by bacterial species harboring a homolog of
the dlt operon like S. pyogenes (Kristian et al., 2005) or S. aureus
(Kraus et al., 2008) are known to be much more resistant against
the antimicrobial activity of cathelicidins. An indirect strategy of
microbes to avoid the antimicrobial effect of ETs is to reduce the
recruitment of immune cells involved in the production of ETs.
This is achieved by the blocking or cleaving of chemotactic medi-
ators involved in the recruitment of immune cells to the site/s of
infection. An example of this is provided by the IL-8 degrading
protein SpyCEP of S. pyogenes (Gupta et al., 2005).
CONCLUDING REMARKS
Despite the large number of studies that have been conducted
on ETs, they still remain enigmatic structures, and many aspects
regarding their nature and signiﬁcance is deserving of further
investigation. The speciﬁc mechanism/s responsible for pathogen
entrapment by ETs is still unsolved. Although some light has
been shed regarding the killing mechanisms employed by ETs,
the actual process is still largely unknown and requires detailed
exploration. In particular, the role of antimicrobial agents like
cathelicidins or histones is still under discussion. The extent to
which the binding of these molecules to DNA may alter their
biological functionality is also unknown. Another question that
remains open is related to why only a small proportion of cells
within the total population are primed to release ETs. This argues
against a primary role of ETs in the functional biology of these
cells. Perhaps, a major function of ETs is to contain the pathogen
at the site of infection, thereby limiting its spread and dissem-
ination. Indeed, this is a feature also ascribed in the late 1980s
to ﬁbrin networks where it was also demonstrated that they were
able to interfere with the phagocytic function of neutrophils by
blocking effective phagocytosis (Bruns et al., 2010). An additional
problem in investigations of the release of ETs is the high variabil-
ity of experimental settings employed by different laboratories.
For example, the concentration of PMA used in different studies
ranges from 20 to 200 μM. Furthermore, in vitro growth condi-
tions such as nutrient and serum supplementation as well as the
time frame for induction are heterogeneous in the literature. This
variability may lead to incorrect assumptions and serious misin-
terpretations.
Future research should be directed to addressing the limitations
of these investigations and detailing the signaling pathways leading
to etosis. More importantly, further insights into the mechanism/s
underlying the regulation of etosis are required. This is of partic-
ular importance given that the process of cell death releases many
biologically active components that may be both beneﬁcial but
also detrimental to the host.
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